Singapore markets close in 6 hours 23 minutes

Minerva Neurosciences, Inc. (NERV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4900+0.1500 (+6.41%)
At close: 04:00PM EDT
2.5100 +0.02 (+0.80%)
After hours: 07:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 17.45M
Enterprise value -17.36M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.68
Enterprise value/revenue 0.03
Enterprise value/EBITDA 0.75

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-67.79%
S&P500 52-week change 325.38%
52-week high 313.4900
52-week low 32.2860
50-day moving average 32.5686
200-day moving average 36.0947

Share statistics

Avg vol (3-month) 3110.14k
Avg vol (10-day) 312.63k
Shares outstanding 56.99M
Implied shares outstanding 67.08M
Float 85.44M
% held by insiders 122.26%
% held by institutions 134.94%
Shares short (15 Apr 2024) 430.48k
Short ratio (15 Apr 2024) 41.25
Short % of float (15 Apr 2024) 40.78%
Short % of shares outstanding (15 Apr 2024) 40.44%
Shares short (prior month 15 Mar 2024) 438.26k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:8
Last split date 321 Jun 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.94%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -24.45M
Net income avi to common (ttm)-31.6M
Diluted EPS (ttm)-4.4300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.82M
Total cash per share (mrq)4.98
Total debt (mrq)84.27M
Total debt/equity (mrq)N/A
Current ratio (mrq)12.58
Book value per share (mrq)-5.23

Cash flow statement

Operating cash flow (ttm)-20.76M
Levered free cash flow (ttm)-18.41M